TSHR/IGF-1R Cross-Talk, Not IGF-1R Stimulating Antibodies, Mediates Graves' Ophthalmopathy Pathogenesis
- 1 May 2017
- journal article
- letter
- Published by SAGE Publications in Thyroid®
- Vol. 27 (5) , 746-747
Abstract
The only peer-reviewed journal focused on the rapidly moving field of 3D printing and related technologies, providing comprehensive coverage of academic research and industrial and commercial developments that have applications in medicine, education, food, and architecture.Keywords
This publication has 4 references indexed in Scilit:
- Building the Case for Insulin-Like Growth Factor Receptor-I Involvement in Thyroid-Associated OphthalmopathyFrontiers in Endocrinology, 2017
- TSH/IGF-1 Receptor Cross Talk in Graves' Ophthalmopathy PathogenesisThe Journal of Clinical Endocrinology & Metabolism, 2016
- How IGF-1 activates its receptoreLife, 2014
- A Modified ELISA Accurately Measures Secretion of High Molecular Weight Hyaluronan (HA) by Graves' Disease Orbital CellsEndocrinology, 2014